CN Patent

CN104490873A — 一种治疗儿童结节性硬化症的药物

Assigned to Individual · Expires 2015-04-08 · 11y expired

What this patent protects

本发明涉及医药领域，具体公开了一种治疗儿童结节性硬化症的药物，所述药物包含雷帕霉素，所述儿童结节性硬化症包括儿童结节性硬化症合并难治性癫痫、儿童结节性硬化症合并心脏横纹肌瘤、儿童结节性硬化症合并色素脱失斑、儿童结节性硬化症合并面部皮脂腺瘤和儿童结节性硬化症合并肾脏血管平滑肌脂肪瘤。所述药物的使用方法，其中，雷帕霉素的起始剂量为1mg/(m 2 ·d)，并维持血药浓度为5-10ng/mL。

USPTO Abstract

本发明涉及医药领域，具体公开了一种治疗儿童结节性硬化症的药物，所述药物包含雷帕霉素，所述儿童结节性硬化症包括儿童结节性硬化症合并难治性癫痫、儿童结节性硬化症合并心脏横纹肌瘤、儿童结节性硬化症合并色素脱失斑、儿童结节性硬化症合并面部皮脂腺瘤和儿童结节性硬化症合并肾脏血管平滑肌脂肪瘤。所述药物的使用方法，其中，雷帕霉素的起始剂量为1mg/(m 2 ·d)，并维持血药浓度为5-10ng/mL。

Drugs covered by this patent

Patent Metadata

Patent number
CN104490873A
Jurisdiction
CN
Classification
—
Expires
2015-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.